Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Jacinta O'Shea from the Nuffield Department of Clinical Neurosciences explains how stimulation of the brains of stroke patients can cause long-lasting improvements.

The patient was asked to distribute flowers equally around the garden. They are all clumped to the right, showing dramatic neglect of left space.

Every year thousands of people are left with debilitating symptoms after stroke. Perhaps one of the most striking is known as hemispatial neglect. This is when right-sided brain damage causes people to behave as though the left half of the world does not exist.

This problem arises when damage to the right parietal cortex disrupts the connections linking visual areas at the back of the brain with motor systems towards the front. The damage leaves the stroke survivor unable to voluntarily direct attention towards, and act on, visual objects in the space to their left.

Hemispatial neglect is very common, affecting many patients in the early months after stroke. Most recover over time, but about one-third do not, and suffer neglect as a lasting disabling condition.

Read more (University of Oxford website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.